Italy· 020689028

VAGILEN

A metronidazole product containing metronidazolo, registered in Italy by DYMALIFE PHARMACEUTICAL S.R.L., on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC P01AB01

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedVAGILENATCP01AB01REGISTER NO.020689028PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Metronidazole is registered in 11 of 19 countries.

Countries holding a registration under ATC P01AB01 (metronidazole), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 7 of them publish a price we can compare per daily dose

Metronidazole · ATC P01AB01

11 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of metronidazole costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in Italy to $6.31 in Switzerland — a ×8.7 gap.

  • Italy: $0.72 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Metronidazole · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.31
  • IT Italy$0.72
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Metronidazolo
Manufacturer
DYMALIFE PHARMACEUTICAL S.R.L.
Country
Italy (IT)
ATC code
P01AB01
ATC class
Metronidazole
Defined daily dose
2 g, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    020689028
    "250 MG CAPSULE" 20 CAPSULE
    EUR 1.59

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

752 interactions on record for metronidazole.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metronidazole · interactions on record

752 records

  • 10 severe
  • 143 moderate
  • 223 minor
  • 376 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • EthanolB05XX04severe
  • AmprenavirJ05AE05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2981e1b7-9613-4d3b-a708-6219261840f6
GET /v1/drugs/2981e1b7-9613-4d3b-a708-6219261840f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"250 MG CAPSULE\" 20 CAPSULE",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Metronidazolo",
  "reference_pack": "20 UNITA' 250 MG - USO ORALE",
  "public_price_eur": 1.59,
  "ssn_reference_price_eur": 2.57
}

See everything about metronidazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.